Related Experiment Video
Updated: May 11, 2026
12:21
Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
Paroxetine hydrochloride: polymorphs and solvatomorphs.
1Center for Pharmaceutical Physics, Milford, NJ, USA.
Summary
Researchers evaluated the crystal forms of paroxetine hydrochloride, identifying four distinct polymorphic and four solvatomorphic structures. This study clarifies the known solid-state landscape for this important pharmaceutical compound.
Area of Science:
- Solid-state chemistry
- Pharmaceutical sciences
- Crystallography
Background:
- Paroxetine hydrochloride is a widely used antidepressant.
- Understanding its solid-state forms (polymorphs and solvates) is crucial for drug formulation and efficacy.
- Previous characterization of paroxetine hydrochloride crystal forms has been fragmented.
Purpose of the Study:
- To comprehensively evaluate the polymorphic and solvatomorphic landscape of paroxetine hydrochloride.
- To determine the total number of authentic crystal forms discovered for paroxetine hydrochloride.
- To consolidate existing knowledge on paroxetine hydrochloride's solid-state forms.
Main Methods:
- Extensive literature and patent survey.
- Critical analysis of reported crystal structures.
- Identification and classification of distinct polymorphic and solvatomorphic forms.
Main Results:
- Four genuine nonsolvated polymorphic forms of paroxetine hydrochloride have been identified.
- Four fully characterized solvatomorphic forms of paroxetine hydrochloride have been documented.
- The study provides a clear overview of the discovered crystal forms.
Conclusions:
- The polymorphic and solvatomorphic landscape of paroxetine hydrochloride is well-defined with a total of eight characterized forms.
- This consolidation aids in understanding and controlling the solid-state properties of paroxetine hydrochloride.
- Further research may focus on the stability and interconversion of these identified forms.
Related Concept Videos
01:21Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
04:01Factors Affecting Solubility
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
02:30Chirality at Nitrogen, Phosphorus, and Sulfur
Chirality is most prevalent in carbon-based tetrahedral compounds, but this important facet of molecular symmetry extends to sp3-hybridized nitrogen, phosphorus and sulfur centers, including trivalent molecules with lone pairs. Here, the lone pair behaves as a functional group in addition to the other three substituents to form an analogous tetrahedral center that can be chiral.
A consequence of chirality is the need for enantiomeric resolution. While this is theoretically possible for all...
A consequence of chirality is the need for enantiomeric resolution. While this is theoretically possible for all...
02:52Stereoisomerism
Isomerism in Complexes
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...